Skip to main content
Back to AI Intelligence Briefing
RegulationAugust 17, 2026Source: Congressional Research Service

FDA Regulation of AI-Enabled Devices

A recent policy brief explains how the FDA regulates AI-enabled health applications as medical devices, balancing safety with access to lower-risk innovations. It details current pathways for authorization, the scope of regulated clinical AI tools, and ongoing debates over how to adapt regulatory frameworks to continuously learning algorithms.

LOG Standards provides this short context and directs readers to the named publisher for the complete report. The source article remains the authoritative account of the underlying reporting.
Read Full Article

About LOG Standards

LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.

Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.